Quality Improvement and Research in Neurology Using Electronic Medical Records
This study aims to improve care for common neurological conditions like brain tumors, epilepsy, migraine, and mild cognitive impairment. Researchers are using electronic medical records (EMR) at NorthShore University HealthSystem to find the most effective treatments. They are testing existing drugs such as lamotrigine, levetiracetam, and valproic acid for brain tumors and epilepsy; donepezil, rivastigmine, and memantine for mild cognitive impairment; and amitriptyline, propranolol, topiramate, sumatriptan, rizatriptan, and zolmitriptan for migraine. You may be able to join if you are 18 to 100 years old and have one of these conditions, along with others like concussion or Parkinson's disease, and are eligible for one of the tested treatments. Success will be measured by how long participants remain on their assigned treatment or avoid disability, depending on their condition. The current recruitment status is unclear.
- Study design
- This is an interventional study, meaning participants will receive specific treatments. It plans to enroll 3300 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for six months for migraine, and for one year for epilepsy and mild cognitive impairment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Quality Improvement and Practice Based Research in Neurology Using the EMR
At a glance
Conditions
NCT02670161
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
NorthShore University HealthSystem
Evanston, Illinoisno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- survival free of discontinuation or alternative prevention drug (migraine trial)six months
- survival free of disability measured by FAQ score 9+ (memory trial)one year
- survival free of discontinuation or alternative anti epileptic drug (epilepsy trial)one year